But regardless of the mechanism, the activation of AhR induces CD39 expression in tumor-associated cells, promotes CD8+ T-cell dysfunction (Takenaka et al., 2019), and promotes Treg cell proliferation to induce immunosuppression (Mezrich et al., 2010), thereby enabling the tumor microenvironment. This evidence concerns the gene ENTPD1 and neoplasm.